Page last updated: 2024-10-25

diazoxide and Islet Cell Tumor, Malignant

diazoxide has been researched along with Islet Cell Tumor, Malignant in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshioka, M1
Shibata, S1
Uchinami, H1
Watanabe, G1
Miyazawa, H1
Iida, M1
Yoshida, M1
Yoshioka, T1
Nanjo, H1
Yamamoto, Y1

Other Studies

1 other study available for diazoxide and Islet Cell Tumor, Malignant

ArticleYear
The transformation of a nonfunctioning islet cell tumor of the pancreas into a proinsulinoma under conditions of lung metastasis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:7

    Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Is

2015